Volume 72, Issue 4
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645


An intervention study was implemented on five Indonesian islands highly endemic for leprosy to determine whether rifampicin can be used as chemoprophylaxis to prevent leprosy. The population was actively screened before the intervention and subsequently once a year for three years. In the control group, no chemoprophylaxis was given. In the contact group, chemoprophylaxis was only given to contacts of leprosy patients and in the blanket group to all eligible persons. The cohort consisted of 3,965 persons. The yearly incidence rate in the control group was 39/10,000; the cumulative incidence after three years was significantly lower in the blanket group ( = 0.031). No difference was found between the contact and the control groups ( = 0.93). Whether this apparent reduced leprosy incidence in the first three years in the blanket group is due to a delayed development of leprosy or a complete clearance of infection needs to be determined.


Article metrics loading...

The graphs shown below represent data from March 2017
Loading full text...

Full text loading...



  1. World Health Organization, 2000. The Final Push Towards Elimination of Leprosy, Strategic Plan 2000–2005. Geneva: World Health Organization.
  2. Feenstra P, 2003. “Elimination” of leprosy and the need to sustain leprosy services, expectations, predictions and reality. Int J Lepr Other Mycobact Dis 71 : 248–256. [Google Scholar]
  3. Cree IA, Smith WC, 1998. Leprosy transmission and mucosal immunity: towards eradication? Lepr Rev 67 : 112–121. [Google Scholar]
  4. Hatta M, van Beers SM, Madjid B, Djumadi A, de Wit MYL, Klatser PR, 1995. Spatial distribution and persistence of Mycobacterium leprae nasal carriage among a population in which leprosy is endemic in Indonesia. Trans R Soc Trop Med Hyg 89 : 381–385. [Google Scholar]
  5. Fine PEM, 1988. BCG vaccination against tuberculosis and leprosy. BMJ 44 : 691–703. [Google Scholar]
  6. Smith CM, Smith WCS, 2000. Chemoprophylaxis is effective in the prevention of leprosy in endemic countries: a systematic review and meta-analysis. J Infect 41 : 137–142. [Google Scholar]
  7. CDC, 2003. Update: adverse event data and revised American Thoracic Society/CDC recommendations against the use of rifampin and pyrazinamide for treatment of latent tuberculosis infection–United States, 2003. MMWR Morb Mortal Wkly Rep 52 : 735–739. [Google Scholar]
  8. Veen J, 1992. Microepidemics of tuberculosis: the stone-in-the-pond principle. Tuber Lung Dis 73 : 73–76. [Google Scholar]
  9. van Beers SM, Hatta M, Klatser PR, 1999. Patient contact is the major determinant in incident leprosy: implication for future control. Int J Lepr Other Mycobact Dis 67 : 119–128. [Google Scholar]
  10. Bakker MI, Hatta M, Kwenang A, Klatser PR, Oskam L, 2002. Epidemiology of leprosy of five isolated islands in the Flores Sea, Indonesia. Trop Med Int Health 7 : 780–787. [Google Scholar]
  11. World Health Organization, 1998. WHO Expert Committee on leprosy. World Health Organ Tech Rep Ser 874 : 1–43. [Google Scholar]
  12. Wardekar RV, 1967. DDS prophylaxis against leprosy. Lepr India 39 : 155–159. [Google Scholar]
  13. Otsyula Y, Ibworo C, Chum HJ, 1971. Four years’ experience with dapsone as prophylaxis against leprosy. Lepr Rev 42 : 98–100. [Google Scholar]
  14. Cartel JL, Chanteau S, Bouting JP, Taylor R, Plichart R, Roux J, Celerier P, Grosset JH, 1989. Implementation of chemoprophylaxis of leprosy in the southern Marquesas with a single dose of 25 mg per kg rifampin. Int J Lepr Other Mycobact Dis 57 : 810–816. [Google Scholar]
  15. Cartel JL, Chanteau S, Moulia-Pelat JP, Plichart R, Glaziou P, Boutin JP, Roux JF, Grosset JH, 1992. Chemoprophylaxis of leprosy with a single dose of 25 mg per kg rifampin in the southern Marquesas; results after four years. Int J Lepr Other Mycobact Dis 60 : 416–420. [Google Scholar]
  16. Nguyen LN, Cartel JL, Grosset JH, 2000. Chemoprophylaxis of leprosy in the southern Marquesas with a single 25 mg/kg dose of rifampicin. Results after 10 years. Lepr Rev 71 : S33–S36. [Google Scholar]
  17. Noordeen SK, 1985. The epidemiology of leprosy. Hastings RC, ed. Leprosy. London: Churchill Livingstone, 15–30.
  18. Fine PEM, 1982. Leprosy: the epidemiology of a slow bacterium. Epidemiol Rev 4 : 161–168. [Google Scholar]
  19. Fine PEM, Sterne JAC, Pönnighaus JM, Fine PE, Sterne JA, Ponnighaus JM, Bliss L, Saui J, Chihana A, Munthali M, Warndorff DK, 1997. Household and dwelling contact as risk factors for leprosy in northern Malawi. Am J Epidemiol 146 : 91–102. [Google Scholar]

Data & Media loading...

  • Received : 08 Oct 2004
  • Accepted : 16 Nov 2004

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error